Zobrazeno 1 - 10
of 397
pro vyhledávání: '"Clift RA"'
Autor:
Buckner Cd, Scott D. Rowley, F R Appelbaum, Clift Ra, R Storb, K Lilleby, Taner Demirer, William I. Bensinger, Barry E. Storer
Publikováno v:
Journal of Clinical Oncology. 15:684-690
PURPOSE To evaluate the effects of chemotherapy regimens on peripheral-blood stem-cell (PBSC) yields in patients with breast cancer who receive granulocyte colony-stimulating factor (G-CSF). PATIENTS AND METHODS One hundred patients with breast cance
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3854302ce5aa7dd5d29cfc7d62ee3cb5
https://doi.org/10.1200/jco.1997.15.2.684
https://doi.org/10.1200/jco.1997.15.2.684
Autor:
C H Weaver, Jean E. Sanders, Claudio Anasetti, Buckner Cd, Taner Demirer, Clift Ra, William I. Bensinger, Finn Bo Petersen, P.J. Martin, K Lilleby
Publikováno v:
Journal of Clinical Oncology. 13:596-602
PURPOSE To evaluate a high-dose chemotherapy regimen without total-body irradiation (TBI) followed by allogeneic (allo) bone marrow transplantation (BMT) in patients with lymphoid malignancies who had received prior dose-limiting radiotherapy. PATIEN
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::14177db76ac824a9dcb789a5562beeb0
https://doi.org/10.1200/jco.1995.13.3.596
https://doi.org/10.1200/jco.1995.13.3.596
Autor:
M H Lynch, William I. Bensinger, P.J. Martin, A Fefer, M C Benyunes, Jean E. Sanders, Kristine Doney, Finn Bo Petersen, Clift Ra, F R Appelbaum
Publikováno v:
Journal of Clinical Oncology. 11:1353-1360
PURPOSE This study compares outcomes of autologous bone marrow transplantation (ABMT) in patients with acute myeloid leukemia (AML) in untreated first relapse (REL1) or in second complete remission (REM2). PATIENTS AND METHODS Forty-seven patients wi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::24a5eb0b2fa544541d8e76f94539f72b
https://doi.org/10.1200/jco.1993.11.7.1353
https://doi.org/10.1200/jco.1993.11.7.1353
Autor:
Buckner Cd, F R Appelbaum, Jack W. Singer, A Fefer, William I. Bensinger, Clift Ra, P Beatty, William S. Dalton, James A. Bianco, Finn Bo Petersen
Publikováno v:
Journal of Clinical Oncology. 10:1492-1497
PURPOSE To study the toxicity and potential efficacy of busulfan (BU) and cyclophosphamide (CY) as a conditioning regimen before allogeneic bone marrow transplantation (ABMT) in patients with multiple myeloma (MM). PATIENTS AND METHODS Twenty patient
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::477e92c7e3c248ba1a8ecd494d0819d3
https://doi.org/10.1200/jco.1992.10.9.1492
https://doi.org/10.1200/jco.1992.10.9.1492
Autor:
Deeg Hj, Jean E. Sanders, Keith M. Sullivan, C. D. Buckner, William I. Bensinger, Finn Bo Petersen, Kristine Doney, Clift Ra, Robert P. Witherspoon, J.A. Hansen, F R Appelbaum, R Storb
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 23:1027-1032
Thirty-six patients with advanced hematologic malignancy were entered into a Phase I study designed to define the maximum tolerated dose of unshielded total body irradiation delivered from dual 60 Cobalt sources at an exposure rate of 8 cGy/min and g
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1a033fa854973fbbd3e22cd275e53097
https://doi.org/10.1016/0360-3016(92)90909-2
https://doi.org/10.1016/0360-3016(92)90909-2
Publikováno v:
Blood. 82:1954-1956
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4a93e592d6985a08b759e1482d880e15
https://doi.org/10.1182/blood.v82.7.1954.1954
https://doi.org/10.1182/blood.v82.7.1954.1954
Autor:
T. Chauncey, P Stewart, Keith M. Sullivan, John T. Slattery, Robert P. Witherspoon, George B. McDonald, Mary E.D. Flowers, Effie W. Petersdorf, Jerry P. Radich, Eileen Bryant, F R Appelbaum, Claudio Anasetti, R Storb, Thomas Ed, Deeg Hj, P.J. Martin, J.A. Hansen, Barry E. Storer, Kristine Doney, Richard A. Nash, E. Soll, William I. Bensinger, Clift Ra, Buckner Cd, Jean E. Sanders, Ted Gooley, Raleigh A. Bowden, Gary Schoch
Publikováno v:
Blood. 89(8)
The influence of busulfan (BU) plasma concentration on outcome of transplantation from HLA identical family members for the treatment of chronic myelogenous leukemia (CML) was examined in 45 patients transplanted in chronic phase (CP) (n = 39) or acc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::415cf188f45ef569b38dcc731a9dc39d
https://pubmed.ncbi.nlm.nih.gov/9108427
https://pubmed.ncbi.nlm.nih.gov/9108427
Autor:
Ted Gooley, F R Appelbaum, Claudio Anasetti, William I. Bensinger, E. Bryant, Gary Schoch, Thomas R. Chauncey, J E Anderson, Clift Ra, Buckner Cd
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 14(1)
PURPOSE To determine if an intensive preparative regimen of busulfan (BU), cyclophosphamide (CY), and total-body irradiation (TBI) could improve outcome after marrow transplantation for advanced morphology myelodysplasia (refractory anemia with exces
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::efe01f7102c6d28e252571fed0c53100
https://pubmed.ncbi.nlm.nih.gov/8648402
https://pubmed.ncbi.nlm.nih.gov/8648402
Autor:
C. Dean Buckner, Clift Ra
Publikováno v:
Cancer Treatment and Research ISBN: 9781461358329
Technical and Biological Components of Marrow Transplantation
Technical and Biological Components of Marrow Transplantation
1. Marrow Transplantation for Chronic Myeloid Leukemia R. Clift. 2. Bone Marrow Transplantation in Thalassemia G. Lucarelli, C. Giardini. 3. High-Dose Chemotherapy and Autologous Stem Cell Transplantation for Breast Cancer C. Weaver. 4. Bone Marrow T
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::17e4917ce4dd200502c931a8045f92bd
https://doi.org/10.1007/978-1-4615-2013-9
https://doi.org/10.1007/978-1-4615-2013-9
Publikováno v:
Acute Leukemias ISBN: 9783540539490
Allogeneic marrow transplantation from HLA-identical siblings for patients with acute myeloid leukemia (AML) in first remission results in approximately 50% survival. Data reported by the Seattle team and the International Bone Marrow Transplant Regi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2ac2e8e3e005808998548f825d93e821
https://doi.org/10.1007/978-3-642-76591-9_87
https://doi.org/10.1007/978-3-642-76591-9_87